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Vaccination with 
pneumococcal 
conjugate 
vaccine before 
12 months of 
age significantly 
reduces the 
incidence of 
both acute 
and recurrent 
otitis media.
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	 Does	pneumococcal	
conjugate	vaccine	prevent		
otitis	media?	
	 yes,	 if	 the	 pneumococcal	 conju-
	 gate	 vaccine	 (PCV)	 series	 is	 given	
before	 12	months	 of	 age.	 Vaccination	 be-
fore	12	months	is	associated	with	a	statisti-
cally	significant	reduction	in	the	incidence	
of	both	acute	(AOM)	and	recurrent	(ROM)	
otitis	 media	 (strength	 of	 recommenda-
tion	 [SOR]:	A,	 a	 systematic	 review	of	 ran-
domized	 controlled	 trials	 [RCTs]	 and	 a	
large	 retrospective	 cohort	 trial).	The	 ben-
efit	disappears	 if	 the	series	 is	started	after	
12	months	(SOR:	B,	a	systematic	review	of	
RCTs	with	inconsistent	results).	
PCV	 reduces	 tympanostomy	 tube	
placement	 for	ROM	(SOR:	A,	 a	 large	RCT	
and	retrospective	cohort	trials).
Evidence summary 
A	 Cochrane	 review	 of	 7	 RCTs,	 with	 a	 total	
of	 46,885	 children,	 examined	 the	 effect	 of	
pneumococcal	 vaccine	 on	 the	 incidence	 of	
otitis	media.1	The	authors	didn’t	pool	the	re-
sults	 because	 of	 large	 heterogeneity	 among	
the	 studies.	 Only	 2	 trials	 used	 the	 licensed	
7-valent	 PCV	Prevnar;	 both	 enrolled	 infants	
vaccinated	according	to	the	routine	schedule	
before	12	months	of	age.	 
The	 largest	 study	 (37,686	 children	 fol-
lowed	to	42	months	of	age)	showed	a	7.8%	 re-
duction	 in	 the	 number	 of	 office	 visits	 for	
otitis	media	after	pneumococcal	vaccination	
(95%	 CI,	 5.4%-10.1%).2	 The	 incidence	 of	
ROM—defined	 as	 at	 least	 3	 episodes	within	
6	months	or	at	least	4	episodes	within	1	year—
decreased	9%	(95%	CI,	4%-14%)	among	vac-
cine	recipients.2	The	study	also	demonstrated	
a	24%	decrease	in	the	need	for	tympanostomy	
tubes	(95%	CI,	12%-35%).2 	The	other	7-valent	
PCV	trial	(1662	children)	showed	a	6%	risk	re-
duction	in	AOM	(95%	CI,	-4%	to	16%)	in	the	
vaccinated	group.1	
A	retrospective	cohort	study	in	New	York	
and	Tennessee	that	enrolled	176,000	children	
vaccinated	 according	 to	 the	 recommended	
schedule	 starting	 at	 2	months	 of	 age	 found	
reductions	in	ROM	of	28%	(95%	CI,	11%-33%)	
for	 New	 York’s	 vaccinated	 cohort	 and	 17%	
(95%	CI,	 6%-19%)	 for	 the	Tennessee	 cohort.	
ROM	was	defined	as	at	least	3	episodes	within	
6	months	or	at	least	4	episodes	within	1	year.	
The	 study	 also	 showed	 a	 23%	 decrease	 in	
tympanostomy	 tube	placement	 in	New	York	
(95%	CI,	1%-35%)	and	a	16%	decrease	in	Ten-
nessee	(95%	CI,	3%-21%).3
A simplified vaccination schedule 
linked to fewer cases of otitis media 
A	single-blinded	prospective	cohort	study	of	
1571	 children	 examined	 the	 effectiveness	 of	
a	simplified	PCV-7	schedule.	Children	vacci-
nated	with	the	licensed	7-valent	PCV	at	3,	5,	
and	11	months	of	age	 showed	a	17%	reduc-
tion	 in	 AOM	 (95%	 CI,	 2%-39%)	 compared	
with	unvaccinated	controls.4	
Vaccination starting at 12 months  
shows mixed results
Results	from	3	trials	that	vaccinated	children	
older	 than	 1	 year	 were	 mixed.1	 An	 analysis	
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of	264	healthy	12-	 to	35-month-olds	given	a	
9-valent	PCV	found	a	17%	reduction	in	AOM	
(95%	CI,	−2%	to	33%).	However,	in	2	other	tri-
als,	of	74	and	383	children,	the	vaccine	didn’t	
decrease	the	incidence	of	AOM.1	
Children	in	these	2	trials	were	1	to	7	years	
of	age	and	all	had	had	at	 least	2	episodes	of	
otitis	 media	 in	 the	 year	 before	 enrollment.	
Both	trials	employed	2	doses	of	the	licensed	
7-valent	PCV	in	children	younger	than	2	years	
and	 1	 dose	 of	 the	 7-valent	 vaccine	 followed	
by	a	dose	of	the	23-valent	vaccine	in	children	
older	than	2	years.1
Recommendations
A	 clinical	 practice	 guideline	 issued	 jointly	
by	 the	American	Academy	of	Pediatrics	and	
American	Academy	of	Family	Physicians	rec-
ognizes	 the	 benefit	 of	 PCV	 vaccination	 for	
preventing	AOM.5	Although	preventing	AOM	
is	 not	 the	 primary	 indication,	 PCV	 vaccina-
tion	at	2,	4,	6,	and	12	 to	15	months	of	age	 is	
part	of	 the	 routine	childhood	 immunization	
series	 recommended	 by	 the	 Advisory	 Com-
mittee	on	Immunization	Practices.6		             JFP
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